Mdl-27192 → 3H-1,2,4-Triazol-3-one, 2,4-dihydro-2,4-dimethyl-5-(2-thienyl)-

HRID 1648247Notizen

Reaktionsgleichung

[S:1]1[CH:5]=[CH:4][CH:3]=[C:2]1[C:6]1[N:7]([CH3:12])[C:8](=[O:11])[NH:9][N:10]=1.Cl[C:14]1C=CC(C2N(CC)C(=O)NN=2)=CC=1>>[S:1]1[CH:5]=[CH:4][CH:3]=[C:2]1[C:6]1[N:7]([CH3:12])[C:8](=[O:11])[N:9]([CH3:14])[N:10]=1

Komponenten

Edukt 2

HCID 35793Mdl-27192

HCID 30882803H-1,2,4-Triazol-3-one, 2,4-dihydro-4-methyl-5-(2-thienyl)-

Produkt 1

HCID 30759843H-1,2,4-Triazol-3-one, 2,4-dihydro-2,4-dimethyl-5-(2-thienyl)-

Versuchsvorschrift

When, in the procedure of Example 7, 5-(2-thienyl)-2,4-dihydro -4-methyl-3H-1,2,4-triazol-3-one is substituted for 5-(4-chlorophenyl)-2,4-dihydro-4-ethyl-3H-1,2,4-triazol-3-one, the title compound is obtained. Mp 108°-110° C.

Quellen und Nachweise

ORD-Eintrag: ord-96289f087e214c76934c9ab02b4a9291
Quelldatensatz: uspto-grants-1995_07
DOI: 10.6084/m9.figshare.5104873.v1
Patentnummer: US05436252

Notizen zur Reaktion

Wird geladen…